Probi AB (publ) (PROB.ST)
SEK 347.0
(-0.29%)
SEK 347.0
(-0.29%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 116.7 Million SEK | 0.4% |
| 2022 | 116.24 Million SEK | 23.9% |
| 2021 | 93.82 Million SEK | -4.65% |
| 2020 | 98.39 Million SEK | 23.77% |
| 2019 | 79.49 Million SEK | 15.76% |
| 2018 | 68.67 Million SEK | -0.67% |
| 2017 | 69.14 Million SEK | -4.96% |
| 2016 | 72.75 Million SEK | 1528.29% |
| 2015 | 4.46 Million SEK | 25.47% |
| 2014 | 3.56 Million SEK | 32.92% |
| 2013 | 2.67 Million SEK | 8.64% |
| 2012 | 2.46 Million SEK | -44.01% |
| 2011 | 4.4 Million SEK | 94.61% |
| 2010 | 2.26 Million SEK | 82.79% |
| 2009 | 1.23 Million SEK | -23.63% |
| 2008 | 1.62 Million SEK | -2.0% |
| 2007 | 1.65 Million SEK | 67.92% |
| 2006 | 985 Thousand SEK | 0.0% |
| 2005 | - SEK | -100.0% |
| 2004 | 1.38 Million SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 128.63 Million SEK | 2.12% |
| 2024 Q2 | 125.96 Million SEK | -0.57% |
| 2024 Q1 | 126.69 Million SEK | 8.56% |
| 2023 Q3 | 131.38 Million SEK | -5.6% |
| 2023 FY | 116.7 Million SEK | 0.4% |
| 2023 Q2 | 139.18 Million SEK | 8.74% |
| 2023 Q1 | 127.99 Million SEK | 10.11% |
| 2023 Q4 | 116.7 Million SEK | -11.18% |
| 2022 Q3 | 111.47 Million SEK | -0.2% |
| 2022 Q2 | 111.7 Million SEK | 3.84% |
| 2022 FY | 116.24 Million SEK | 23.9% |
| 2022 Q4 | 116.24 Million SEK | 4.28% |
| 2022 Q1 | 107.57 Million SEK | 14.66% |
| 2021 Q3 | 96.2 Million SEK | -2.66% |
| 2021 Q2 | 98.83 Million SEK | -11.57% |
| 2021 Q1 | 111.75 Million SEK | 13.58% |
| 2021 Q4 | 93.82 Million SEK | -2.48% |
| 2021 FY | 93.82 Million SEK | -4.65% |
| 2020 Q3 | 109 Million SEK | 2.06% |
| 2020 Q1 | 76.75 Million SEK | -3.45% |
| 2020 FY | 98.39 Million SEK | 23.77% |
| 2020 Q2 | 106.8 Million SEK | 39.16% |
| 2020 Q4 | 98.39 Million SEK | -9.73% |
| 2019 Q4 | 79.49 Million SEK | -2.53% |
| 2019 FY | 79.49 Million SEK | 15.76% |
| 2019 Q3 | 81.56 Million SEK | 18.16% |
| 2019 Q2 | 69.02 Million SEK | -0.67% |
| 2019 Q1 | 69.49 Million SEK | 1.19% |
| 2018 FY | 68.67 Million SEK | -0.67% |
| 2018 Q4 | 68.67 Million SEK | -8.79% |
| 2018 Q3 | 75.29 Million SEK | -4.94% |
| 2018 Q2 | 79.2 Million SEK | 8.61% |
| 2018 Q1 | 72.92 Million SEK | 5.47% |
| 2017 Q4 | 69.14 Million SEK | -5.11% |
| 2017 Q1 | 75.35 Million SEK | 3.57% |
| 2017 Q3 | 72.86 Million SEK | -2.19% |
| 2017 Q2 | 74.49 Million SEK | -1.13% |
| 2017 FY | 69.14 Million SEK | -4.96% |
| 2016 FY | 72.75 Million SEK | 1528.29% |
| 2016 Q1 | 5.47 Million SEK | 22.56% |
| 2016 Q3 | 8.69 Million SEK | 14.48% |
| 2016 Q2 | 7.59 Million SEK | 38.73% |
| 2016 Q4 | 72.75 Million SEK | 736.52% |
| 2015 Q1 | 7.6 Million SEK | 113.59% |
| 2015 FY | 4.46 Million SEK | 25.47% |
| 2015 Q4 | 4.46 Million SEK | 24.15% |
| 2015 Q3 | 3.59 Million SEK | -35.04% |
| 2015 Q2 | 5.54 Million SEK | -27.16% |
| 2014 FY | 3.56 Million SEK | 32.92% |
| 2014 Q4 | 3.56 Million SEK | 48.25% |
| 2014 Q2 | 3.26 Million SEK | 21.05% |
| 2014 Q1 | 2.69 Million SEK | 0.56% |
| 2014 Q3 | 2.4 Million SEK | -26.34% |
| 2013 Q3 | 4.83 Million SEK | 14.17% |
| 2013 FY | 2.67 Million SEK | 8.64% |
| 2013 Q4 | 2.67 Million SEK | -44.58% |
| 2013 Q2 | 4.23 Million SEK | 80.86% |
| 2013 Q1 | 2.34 Million SEK | -5.07% |
| 2012 Q1 | 3.63 Million SEK | -17.55% |
| 2012 Q4 | 2.46 Million SEK | -31.44% |
| 2012 Q3 | 3.59 Million SEK | 2.98% |
| 2012 Q2 | 3.49 Million SEK | -3.8% |
| 2012 FY | 2.46 Million SEK | -44.01% |
| 2011 Q3 | 5.58 Million SEK | 4.06% |
| 2011 Q2 | 5.36 Million SEK | 78.08% |
| 2011 Q4 | 4.4 Million SEK | -21.17% |
| 2011 FY | 4.4 Million SEK | 94.61% |
| 2011 Q1 | 3.01 Million SEK | 33.23% |
| 2010 Q4 | 2.26 Million SEK | 0.0% |
| 2010 FY | 2.26 Million SEK | 82.79% |
| 2009 FY | 1.23 Million SEK | -23.63% |
| 2008 FY | 1.62 Million SEK | -2.0% |
| 2007 FY | 1.65 Million SEK | 67.92% |
| 2006 FY | 985 Thousand SEK | 0.0% |
| 2005 FY | - SEK | -100.0% |
| 2004 FY | 1.38 Million SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AcuCort AB | -1.09 Million SEK | 10719.199% |
| AlzeCure Pharma AB (publ) | -2508.00 SEK | 4653409.41% |
| BioGaia AB (publ) | 181.2 Million SEK | 35.595% |
| Enzymatica AB (publ) | 11.49 Million SEK | -914.914% |
| Enorama Pharma AB (publ) | 4.29 Million SEK | -2619.129% |
| Gabather AB (publ) | -1772.00 SEK | 6586160.948% |
| Klaria Pharma Holding AB (publ.) | - SEK | -Infinity% |
| Moberg Pharma AB (publ) | 7.11 Million SEK | -1540.267% |
| Nanexa AB (publ) | 1.91 Million SEK | -6007.012% |
| Newbury Pharmaceuticals AB (publ) | 4.99 Million SEK | -2236.436% |
| ODI Pharma AB | - SEK | -Infinity% |
| Orexo AB (publ) | 42.4 Million SEK | -175.248% |
| Swedencare AB (publ) | 398.1 Million SEK | 70.685% |
| Swedish Orphan Biovitrum AB (publ) | 3.87 Billion SEK | 96.987% |
| Toleranzia AB | -1.34 Million SEK | 8809.328% |
| Vivesto AB | - SEK | -Infinity% |